Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation
NCT00964496Phase 2Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Nov 2004
- Primary completion
- Nov 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of thalidomide in gastrointestinal bleeding, vascular malformation, sponsored by Shanghai Jiao Tong University School of Medicine. Started Nov 2004; status: completed.
02
Drugs
thalidomide
03
Conditions
gastrointestinal bleedingvascular malformation
Beyond the preview
Go deeper on NCT00964496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00964496.